Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
Comparison of Vaginal Progesterone With Arabin Cervical Pessary and Vaginal Progesterone Alone in the Prevention of Preterm Delivery in Singleton Pregnancies With Incidental Premature Shortening of Cervical Length
Sponsor: University of Illinois at Chicago
Terminated
Former PI Left the Institution
Other terminated trials from University of Illinois at Chicago
A PHASE3 clinical study on Focus: Prevent Preterm Delivery and Incidental Short Cervix at Mid-trimester, this trial is terminated or withdrawn. The trial is conducted by University of Illinois at Chicago and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Apr 2020 — Sep 2020 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
▶ Show 3 earlier versions
-
Nov 2018 — Apr 2020 [monthly]
Recruiting PHASE3
Phase: NA → PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Illinois at Chicago
For direct contact, visit the study record on ClinicalTrials.gov .